Methotrexate nephrotoxicity: a pragmatic approach
Identification of emerging risk factors, advances in pharmacogenomics, and timely methotrexate monitoring, combined with patient-specific pharmacokinetic modeling, underscore the importance of personalized therapeutic strategies to reduce renal toxicity and DME.
Authors
- Jaya Kala (ORCID: https://orcid.org/0000-0003-2056-1721)
- Yara Mouawad
Institutions
- The University of Texas Health Science Center (US)
Publication Details
- Journal
- Current Opinion in Nephrology & Hypertension
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1097/mnh.0000000000001144
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00